Guangdong company spearheads efforts to help prevent and eradicate killer disease

Chinese medicines could well prove to be the panacea for African nations in tackling malaria, a disease that accounts for the greatest number of deaths on the continent.

While big donors such as the US-based Gates Foundation and British drugmaker GlaxoSmithKline are spearheading the fight by spending huge amounts on long-term solutions such as preventive vaccines, valuable support is also being provided by Chinese drug firms with medicines that seek to stop the disease at the carrier stage.